The business world was thrilled last week as Springer Nature, the academic publishing giant, floated its shares in Germany, which led to the company being valued at £3.8 billion. But profits should not come at the expense of scholarly integrity and Springer Nature’s record of capitulation to Chinese censorship ought to have raised far greater